CARD10 and ovarian carcinoma: In ovarian cancer, the authors also noted that CARMA3 knockdown increased the cytotoxic effects of cisplatin on tumor cells, again pointing to a possible mechanism by which C3BM signaling promotes resistance to genotoxic chemotherapy.